RPD logo

Royalty Pharma DB:RPD Stock Report

Last Price

€23.55

Market Cap

€14.2b

7D

-4.5%

1Y

-8.9%

Updated

13 Dec, 2024

Data

Company Financials +

Royalty Pharma plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Royalty Pharma
Historical stock prices
Current Share PriceUS$23.55
52 Week HighUS$28.96
52 Week LowUS$23.44
Beta0.46
1 Month Change-3.17%
3 Month Change-4.46%
1 Year Change-8.90%
3 Year Change-31.54%
5 Year Changen/a
Change since IPO-27.76%

Recent News & Updates

Recent updates

Shareholder Returns

RPDDE PharmaceuticalsDE Market
7D-4.5%0.4%-0.09%
1Y-8.9%-12.3%9.1%

Return vs Industry: RPD exceeded the German Pharmaceuticals industry which returned -10.8% over the past year.

Return vs Market: RPD underperformed the German Market which returned 9.6% over the past year.

Price Volatility

Is RPD's price volatile compared to industry and market?
RPD volatility
RPD Average Weekly Movement3.3%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.5%

Stable Share Price: RPD has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: RPD's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996n/aPablo Legorretawww.royaltypharma.com

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies.

Royalty Pharma plc Fundamentals Summary

How do Royalty Pharma's earnings and revenue compare to its market cap?
RPD fundamental statistics
Market cap€14.15b
Earnings (TTM)€1.09b
Revenue (TTM)€2.16b

9.6x

P/E Ratio

4.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RPD income statement (TTM)
RevenueUS$2.27b
Cost of RevenueUS$491.91m
Gross ProfitUS$1.77b
Other ExpensesUS$628.98m
EarningsUS$1.15b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.58
Gross Margin78.29%
Net Profit Margin50.53%
Debt/Equity Ratio74.2%

How did RPD perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

32%

Payout Ratio